Contract facts
UnrestrictedNo full NAICS 339113 intel page yet. Browse NAICS intelligence
Pipette Calibration Service On-Site Pipette Calibration 1 Channel-APPROX. 250 in Accordance with the PWS. Third Option… is a federal Unrestricted award for W40m Mrco Europe held by Meditrade Medical Trading Gmbh. Estimated value $152K ($81K obligated). Current period of performance ends May 31, 2027 (potential May 31, 2028). Last award drew 1 bidder. Related solicitation W9114F23Q0033.
Pipette calibration service on-site pipette calibration 1 channel-approx. 250 in accordance with the pws. third option - 1 june 2026 thru 31 may 2027. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends May 31, 2027 (224 days remaining). Agencies typically plan 12–18 months ahead — at 7.4 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on W9114F23P0034? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordMeditrade Medical Trading Gmbh — $5.0M obligated across 671 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W9114F23P0034?
W9114F23P0034 (Pipette calibration service on-site pipette) is a W40m Mrco Europe award with a potential value of $152K, currently held by Meditrade Medical Trading Gmbh. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W9114F-23-P-0034?
W9114F-23-P-0034 is the dashed form of PIID W9114F23P0034 (Pipette calibration service on-site pipette), held by Meditrade Medical Trading Gmbh. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W9114F23P0034?
W40m Mrco Europe awarded W9114F23P0034 to Meditrade Medical Trading Gmbh (potential $152K).
Who is the incumbent on W9114F23P0034?
Meditrade Medical Trading Gmbh is the incumbent with $5.0M across 671 related awards in SCOUT’s public footprint. The current period of performance ends May 31, 2027.
When does Meditrade Medical Trading Gmbh’s W9114F23P0034 come up for recompete?
SCOUT tracks a period-of-performance end of May 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W9114F23P0034? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.